Drugs / PRO 2000/5
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT00262106 Comparator | Oct 2005 → Aug 2008 | HIV infectious disease, chlamydia infectious disease, genital herpes, gonorrhea | Endo USA Inc., a Keenova Therapeutics Company | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PRO 2000/5 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00262106 ↗ |